EMA prepares for Brexit

Business continuity plan aims to preserve Agency’s ability to protect public and animal health

The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /